Autoassembling peptides for the treatment of pulmonary bulla
US-10245299-B2 · Apr 2, 2019 · US
US12006085B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12006085-B2 |
| Application number | US-202217832612-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 4, 2022 |
| Priority date | Jul 6, 2012 |
| Publication date | Jun 11, 2024 |
| Grant date | Jun 11, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The enclosed disclosure describes, among other things, a method including the steps of a first deaerating step in which a mixture comprising peptides is deaerated by lowering the pressure, filtering the mixture through a sterilizing filter; and a second deaerating step, in which the filtrate is deaerated by vibration and lowering the pressure.
Opening claim text (preview).
The invention claimed is: 1. A method for deaerating and sterilizing a self-assembling peptide solution having at least 0.5 weight % of a self-assembling peptide, the method comprising the steps of: a first deaerating step wherein the self-assembling peptide solution is deaerated by lowering a pressure on the self-assembling peptide solution to vacuum; filtering the self-assembling peptide solution through a sterilizing filter thereby producing a self-assembling peptide filtrate; and a second deaerating step wherein the filtrate is deaerated by vibration at a vibration frequency between 20 and 360 revolutions per minute, and by lowering the pressure on the self-assembling peptide filtrate by at least 0.05 MPa. 2. The method of claim 1 , wherein the sterilizing filter has an average pore size of less than 0.22 μm. 3. The method of claim 1 , wherein the self-assembling peptide comprises one of RADA16-I (SEQ ID NO:1), IEIK13 (SEQ ID NO:39); and KLDL12 (SEQ ID NO:12). 4. The method of claim 1 , wherein the first deaerating step comprises lowering the pressure at a rate of less than 0.01 MPa/min. 5. The method of claim 1 , wherein the first deaerating step occurs in a deaeration chamber and comprises lowering the pressure by at least 0.095 MPa. 6. The method of claim 5 , wherein the pressure is lowered by at least 0.095 MPa for at least 30 minutes. 7. The method of claim 1 , wherein an eccentric distance of the vibration is between −10 cm and 10 cm. 8. The method of claim 1 , wherein the second deaerating step comprises lowering the pressure by at least 0.095 MPa. 9. The method of claim 1 , wherein a step of sterilizing is performed with one of ethylene oxide gas and a hydrogen peroxide gas. 10. The method of claim 1 , wherein the sterilizing filter is constructed from a material selected from the group consisting of the following: cellulose nitrate, cellulose acetate, vinyl polymers, fluorocarbons, polyethylene, ultrahigh molecular weight polyethylene, polypropylene, EVA copolymers and alpha olefins, metallocene olefinic polymers, PFA, MFA, PTFE, polycarbonates, vinyl copolymers, polyamides, nylon, polyesters, cellulose, regenerated cellulose, cellulose composites, polysulfone, polyethersulfone, polyarylsulfone, polyphenylsulfone, polyacrylonitrile, polyvinylidene fluoride (PVDF), and blends thereof. 11. The method of claim 1 , wherein the sterilizing filter is constructed from polyethersulfone. 12. The method of claim 1 , wherein the filtering step comprises a step of filling the sterilizing filter at a first pressure, then increasing the pressure to perform the filtration. 13. The method of claim 1 , wherein the sterilizing filter is washed prior to an integrity test. 14. The method of claim 13 , wherein the sterilizing filter is washed with water prior to the integrity test, and the water is one of above 70° C. and high-pressure of 0.5 MPa or more, or both. 15. The method of claim 1 , wherein the filtering step is performed with two filters operating in parallel.
having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68) · CPC title
Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged · CPC title
Sterilising wrappers or receptacles prior to, or during, packaging {(sterilising bottles B67C7/00)} · CPC title
Filling medical containers such as ampoules, vials, syringes or the like · CPC title
Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.